ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,278.36
1.59%
S&P 500
5,297.10
0.00%
Dow Jones
39,869.38
0.00%
US Dollar vs Yen
155.7695
0.25%
Brent Oil
83.285
0.10%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NYSE
  6. Nevro Corp (NVRO)

  7. Nevro Corp (NVRO) ニュース

NVRO

Nevro (NVRO)

Nevro Corp
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NYSE:NVRO
日付受信時刻ニュースソース見出しコード企業名
2024/05/1005 : 52Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
2024/05/1005 : 05PR Newswire (US)Nevro to Present at BofA Securities 2024 Healthcare ConferenceNYSE:NVRONevro Corp
2024/05/0805 : 56Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NVRONevro Corp
2024/05/0805 : 11Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
2024/05/0805 : 05PR Newswire (US)Nevro Reports First-Quarter 2024 Financial ResultsNYSE:NVRONevro Corp
2024/04/1721 : 30PR Newswire (US)Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024NYSE:NVRONevro Corp
2024/03/1205 : 53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
2024/03/1205 : 52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
2024/03/1205 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
2024/03/1205 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
2024/03/1205 : 49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
2024/03/0708 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
2024/03/0606 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
2024/03/0606 : 16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
2024/03/0606 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
2024/03/0207 : 56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
2024/03/0207 : 55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
2024/02/2906 : 10PR Newswire (US)Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral ScrewNYSE:NVRONevro Corp
2024/02/2407 : 08Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:NVRONevro Corp
2024/02/2306 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
2024/02/2306 : 16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVRONevro Corp
2024/02/2206 : 11Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
2024/02/2206 : 09Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
2024/02/2206 : 06PR Newswire (US)Nevro Enters Into Cooperation Agreement With Engaged CapitalNYSE:NVRONevro Corp
2024/02/2206 : 05PR Newswire (US)Nevro Reports Fourth-Quarter and Full-Year 2023 Financial ResultsNYSE:NVRONevro Corp
2024/02/1505 : 47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:NVRONevro Corp
2024/02/1505 : 38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:NVRONevro Corp
2024/02/0206 : 30PR Newswire (US)Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic NeuropathyNYSE:NVRONevro Corp
2024/01/3006 : 30PR Newswire (US)Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024NYSE:NVRONevro Corp
2024/01/1906 : 15PR Newswire (US)Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic NeuropathyNYSE:NVRONevro Corp
 Showing the most relevant articles for your search:NYSE:NVRO

最近閲覧した銘柄

USI
USTECH100
US Tech 100
NASDAQ
AAPL
Apple
NYSE
BAC
Bank of America
NYSE
MRK
Merck
AMEX
XLF
Financial Select Sector
AMEX
XLE
Energy Select Sector SPDR
CCOM
US30
US 30
FX
USDJPY
US Dollar vs Yen
COIN
BTCUSD
Bitcoin
NASDAQ
NVDA
NVIDIA
COIN
SOLUSD
Solana
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
GOOGL
Alphabet
FX
USDEUR
US Dollar vs Euro
PM
XAUUSD
Gold vs US Dollar
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有